- Regular article
- Open Access
NUP155 insufficiency recalibrates a pluripotent transcriptome with network remodeling of a cardiogenic signaling module
BMC Systems Biologyvolume 12, Article number: 62 (2018)
Atrial fibrillation is a cardiac disease driven by numerous idiopathic etiologies. NUP155 is a nuclear pore complex protein that has been identified as a clinical driver of atrial fibrillation, yet the precise mechanism is unknown. The present study employs a systems biology algorithm to identify effects of NUP155 disruption on cardiogenicity in a model of stem cell-derived differentiation.
Embryonic stem (ES) cell lines (n = 5) with truncated NUP155 were cultured in parallel with wild type (WT) ES cells (n = 5), and then harvested for RNAseq. Samples were run on an Illumina HiSeq 2000. Reads were analyzed using Strand NGS, Cytoscape, DAVID and Ingenuity Pathways Analysis to deconvolute the NUP155-disrupted transcriptome. Network topological analysis identified key features that controlled framework architecture and functional enrichment.
In NUP155 truncated ES cells, significant expression changes were detected in 326 genes compared to WT. These genes segregated into clusters that enriched for specific gene ontologies. Deconvolution of the collective framework into discrete sub-networks identified a module with the highest score that enriched for Cardiovascular System Development, and revealed NTRK1/TRKA and SRSF2/SC35 as critical hubs within this cardiogenic module.
The strategy of pluripotent transcriptome deconvolution used in the current study identified a novel association of NUP155 with potential drivers of arrhythmogenic AF. Here, NUP155 regulates cardioplasticity of a sub-network embedded within a larger framework of genome integrity, and exemplifies how transcriptome cardiogenicity in an embryonic stem cell genome is recalibrated by nucleoporin dysfunction.
Electrical disorders in the heart are a hallmark feature of a class of clinical cardiac pathologies called arrhythmias that are the underlying substrate for heart failure, stroke and sudden cardiac death [1, 2]. The most common sustained arrhythmia observed in a clinical setting is atrial fibrillation (AF), with a population prevalence that increases with aging . AF is defined as a sustained supraventricular tachyarrhythmia with disorganized atrial activation and ineffective contraction that has distinctive electrocardiogram characteristics including: fast atrial rate of ~ 300 beats/min; absence of P waves; and irregular R-R intervals [1, 4]. This type of sustained arrhythmia is accompanied by co-morbidities in the elderly, where the majority of this cohort presents with concomitant structural alterations of the heart . Even though AF is more prevalent in octogenarians, a percentage of patients less than 60 years of age appear in the clinic with a “healthy heart” history. These individuals are diagnosed with idiopathic or lone AF, an unexplained arrhythmia where clinical studies report inconclusive or negative results . Studies to address this gap in knowledge have focused on ion channel gene variants, however recent work has attributed significant contributions of several non-ion channel substrates to AF [6,7,8]. Among these, nucleoporins (nups) have emerged as potential epigenomic regulatory proteins.
Nups comprise the nuclear pore complexes (NPCs), which are large toroidal structures with a main function of directing the selective transport of macromolecules between the cytoplasm and the nucleus. NPCs were first described in Xenopus oocytes using electron microscopy, with modern understanding of its intricate structure and morphology revealed by advanced techniques such as cryo-electron microscopy (cryo-EM) and super-resolution microscopy [9, 10]. NPCs are composed of cytoplasmic, inner, and nucleoplasmic rings, each of which consists of multiple copies of nups stacked and linked together to form distinct NPC subcomplexes [10, 11]. Furthermore, interactions among discrete NPC subcomplexes create specialized structural and functional domains within the pore. For example, the Y-subcomplex is a well characterized component of the NPC that interacts with the inner ring subcomplex to form the NPC scaffold . Recent studies in eukaryotes have revealed that apart from their canonical function as architectural components of the pore and nucleocytoplasmic transport mediators, nups play a significant role in regulation of transcriptional activity and chromatin structure/organization that impacts phenotype [13,14,15]. Indeed, nup-driven differentiation is conserved among a variety of metazoans, where nups play active roles in development [16,17,18].
Moreover, altered nup dynamics have been associated with normal and pathologic cardiogenesis, with a range of clinical phenotypes that range from morphological defects to contractile and electrical impairment of heart function [19, 20]. For example, some components of the NPC inner ring subcomplex affect nuclear localization and histone acetylation of the HOXA gene cluster that underlies mesodermal development and proper cardiac morphology [21, 22]. Disrupted NUP188 results in congenital heart defects (CHD) associated with left-right patterning disorders . Idiopathic and dilated cardiomyopathy, in which myocardial function is progressively impaired, is associated with NDC1, NUP160, NUP153, NUP93, and NUP62 expression changes that together disrupt nuclear transport [20, 24]. Intracellular acidification associated with ischemic cardiac disease was reported to be regulated in part by NUP35 through its ability to bind the 5’ UTR of nhe1, an mRNA that encodes a sodium-hydrogen exchanger essential for maintaining pH homeostasis in cardiomyocytes . NUP155, being a critical scaffolding component of the NPC, in a homozygous mutant form has been shown to impair atrial electrical signaling and give rise to clinical atrial fibrillation . This presents as ectopic initiation of contraction, reentrant impulses, and futile cycling that ultimately compromises cardiac function and leads to sudden death in early childhood . In contrast to the nup-associated cardiopathologies described above, the precise cellular and molecular mechanisms by which NUP155 contributes to supraventricular arrhythmias such as atrial fibrillation remains unknown.
Systems and network biology algorithms can identify cryptogenic drivers of AF through high throughput dataset cartography. This approach has been used to profile cardiogenic transcriptome changes and capture remodeled intermolecular relationships to identify categories of functional perturbation in a cardiopathological model of differentiation [26, 27]. Here, a network-based bioinformatic strategy was applied to decipher complex systems biology impacts of NUP155 disruption in an embryonic stem cell line that models mammalian arrhythmogenesis. This work is the first to characterize pluripotent transcriptome remodeling regulated by NUP155, where we identify novel and high value NUP155-regulated candidates associated with AF etiology. Significantly, transcriptome networks that arise from NUP155 insufficiency revealed alterations in membrane function and extracellular interactions, and specifically identified NTRK1/TRKA and SRSF2/SC35 as hubs essential to the integrity of a cardiogenic sub-network.
All media and reagents have been procured from Fisher Scientific, unless specifically noted. NUP155-deficient embryonic stem cell lines along with wild type parental cell lines were obtained from Bay Genomics (Berkeley, CA).
Embryoid body formation and Ca2+ imaging
Embryoid body (EB) formation and imaging to measure Ca2+ transients in contractile EBs was performed as previously described [26, 28]. Mouse embryonic stem (ES) cells were maintained in Glasgow’s Minimum Essential Medium (GMEM, Gibco) supplemented with penicillin G/streptomycin (Pen/Strep), sodium pyruvate (Lonza BioWhittaker), non-essential amino acids (NEAA, Corning), β-mercaptoethanol (β-ME, Sigma-Aldrich), 7.5% fetal bovine serum (FBS, EMD Millipore) and ESGRO leukemia inhibitory factor (LIF, EMD Millipore), and passaged three times to establish stable growth before embryoid body (EB) formation. ES cell lines were differentiated into three-layered EBs using the hanging-drop method. Briefly, cells were harvested and resuspended in differentiation medium that contained 20% FBS without LIF, to a concentration of 8 × 104 cells/ml. To facilitate EB formation, hanging drops were created by depositing 25 μl of the cell suspension on the lids of 500-cm2 square culture plates and incubated for 48 h. To induce spontaneous differentiation, EBs were flushed and transferred to floating suspension for another 48 h. Following differentiation, cells were cultured in differentiation media containing GMEM supplemented with Pen/Strep, sodium pyruvate, NEAA, β-ME and 20% FBS. Alternatively, Aggrewell (STEMCELL Technologies Inc., Cambridge, MA) plates were used to promote uniform EB size and organization and were cultured in differentiation media as described above. EBs were grown for three days, with media changes as necessary before transferring to gelatin coated dishes. Beating foci could be observed between 5 and 7 days after plating.
Ca2+ imaging: Contractile EBs were incubated in Tyrode’s solution at 37 °C and then loaded with the Ca2+ indicator dye, Fluo-4-AM (5 μM) for 15 min. Stained EBs were imaged with a Zeiss LSM Live 5 laser confocal microscope (Zeiss, Oberkochen, Germany). Spontaneous Ca2+ transients were recorded at 37 °C using ZEN 2.1 software (Zeiss, Oberkochen, Germany), and plotted as a function of time using Excel (Microsoft, Redmond, WA).
Cell culture and RNA extraction
Wild type (WT) and NUP155 exon truncated E14TG2a.4 (NUP155+/−) feeder independent mouse ES cell lines were cultured on 0.1% gelatin coated 100 mm dishes grown in 10 ml of GTES medium consisting of 85% Glasgow MEM (GMEM), 15% ES qualified Fetal Bovine Serum (FBS), sodium pyruvate, non-essential amino acids (NEAA), penicillin/streptomycin (PenStrep), β-mercaptoethanol (β-ME) and ESGRO Leukemia Inhibitory Factor (LIF). After initial plating (seeding density at 1.0 × 106–1.5 × 106 cells), cells were maintained in culture for 2–3 passages, changing GTES media as required. At approximately 80% confluency, cells were passaged by treatment with 5 ml of 0.25% trypsin for 4 min at 37 °C. Trypsin digestion was arrested by addition of an equal amount of GTES media. This suspension was centrifuged at 1500 rpm for 4 min, and pellets of cells were either resuspended in GTES media to be re-plated or in PBS prior to RNA extraction. Total RNA was extracted with an RNeasy Mini kit according to manufacturer’s protocol (Qiagen, Germantown, MD) in preparation for sequencing on HiSeq 2000 System (Illumina, San Diego, CA).
Interrogation of previously published Gene Expression Omnibus (GEO) dataset ID# GDS3729 was performed via Genespring GX to prioritize cardiogenic nup candidates. To determine nup genes that demonstrated consistent and significant changes in expression during cardiogenesis, differential gene expression analysis and self-organizing map (SOM) classification were independently performed between undifferentiated LIF+ ES cells (ES LIF+) and stem cell-derived cardiomyocytes (CM). For increased resolution of WT and NUP155-deficient ES transcriptomes, five independent biological replicates of WT and NUP155+/− lines (n = 10 total) were submitted for RNAseq. RNA libraries were prepared according to the manufacturer’s instructions for the TruSeq RNA Sample Prep Kit v2 (Illumina, San Diego, CA) from 100 ng of total RNA. Briefly, polyA mRNA was purified from total RNA using oligo dT magnetic beads. Purified mRNA was fragmented at 95 °C for 8 min and eluted from the beads. Double stranded cDNA was prepared using SuperScript III reverse transcriptase, random primers (Invitrogen, Thermo Fisher Scientific, Waltham, MA) and DNA polymerase I and RNase H. The cDNA ends were repaired and an “A” base added to the 3′ ends. TruSeq paired end index DNA adaptors (Illumina, San Diego, CA) with a single “T” base overhang at the 3′ end were ligated and resulting constructs were purified using AMPure SPRI beads (Agencourt Bioscience, Beverly, MA). The adapter-modified DNA fragments were enriched by 12 cycles of PCR using Illumina TruSeq PCR primers (Illumina, San Diego, CA). The concentration and size distribution of the libraries were determined using an Agilent Bioanalyzer DNA 1000 chip (Agilent Technologies, Santa Clara, CA) and Qubit fluorometry (Invitrogen, Thermo Fisher Scientific, Waltham, MA).
Libraries were sequenced at 5 samples per lane to generate 70–90 million reads per sample following Illumina’s standard protocol using the Illumina cBot and cBot Paired end cluster kit version 3. The flow cells were sequenced as 101 × 2 paired end reads on an Illumina HiSeq 2000 using TruSeq SBS sequencing kit version 3 and HCS v2.0.12 data collection software. Base-calling was performed using Illumina’s RTA v126.96.36.199. This data was deposited into the NIH GEO database with accession number GSE111596.
Determination of loss of function intolerance metrics and differential expression analysis
The Exome Aggregation Consortium (ExAC) browser was used to investigate pathological potential of our identified nups . Data extracted from the ExAC browser included probability of loss of function (LoF) intolerance (pLI) metric, and z scores for missense metrics .
For RNAseq bioinformatics, raw reads (as *.bam files) were imported into Strand NGS for expression analysis (Agilent Technologies, Santa Clara, CA). Samples were aligned to the Mus musculus genome (Build mm10) and annotated using RefSeq (Release 80). Unmatched paired-end reads were filtered out for downstream quality control. These datasets were further refined by removing reads that did not reach a mapping quality above 20, as well as those that did not surpass vendor-established quality control (QC) criteria in Strand NGS (Agilent Technologies, Santa Clara, CA).
Final QC reads were normalized by DESeq with median of all samples used as baseline. All reads represented a total of 36,172 gene entities that were indexed according to fold change and statistical significance, using the criteria of a 2.0-fold change (or greater) and possessing a p-value of 0.05 or less to identify a quality filtered transcriptome, for a total of 326 genes.
Gene ontology analysis, and network cartography
This signature transcriptome was separated into upregulated (176 entities) and downregulated (150 entities) groups for functional annotation, KEGG, and Reactome pathway enrichment analysis using DAVID Bioinformatics Resources [31,32,33,34]. To determine over representation or enrichment, the DAVID algorithm employs a modified Fisher’s exact test that is incorporated into a score that reports relative priority . Gene lists defined for each cluster were submitted to DAVID using Entrez Gene identifiers for downstream analyses. The highest classification stringency was selected to maintain robust groups and scores were reported for KEGG and Reactome pathways when applicable.
To map functional interactions among genes within the quality filtered transcriptome, the total gene list was submitted to Ingenuity Pathway Analysis (IPA; Qiagen, Germantown, MD) to identify subnetworks within the transcriptome, and construct an integrated de novo gene regulatory network (GRN) to determine overall functional priorities and network topology. A total of 10 subnetworks were identified that were assembled into one inclusive network using the “Merge Networks” function within IPA. Edges within this collective network indicate functional interactions among genes, supported by published empirical observations curated within the IPA database. These relationship data were collated and exported in .xls format using the “Export Data ➔ Export ➔ All Relationships” feature within IPA, and served as an input file for network analysis in Cytoscape . Graph theory metrics, to quantify network structure and topology, were determined using the “Network Analyzer” tool in Cytoscape, and data was used to prioritize gene targets for further analysis.
Discrete nucleoporin gene expression changes in cardiogenesis
Cardiac fate is regulated by temporospatial gene expression , and nucleoporins are emerging as key players in the determination of cardiac structure and function. Previous gene expression analysis in a model of stem cell-derived cardiogenesis revealed global down-regulation of nuclear transport genes with cardiac differentiation . To gain novel insights into nup expression dynamics in cardiogenesis, we performed a nup-focused SOM cluster analysis of our original GEO dataset GDS3729 and identified a unique nup gene set that contained Nup153, Nup155, Nup85, Rae1, and Tpr. (Fig. 1a). Analysis of these genes using the.
Exome Aggregation Consortium (ExAC) browser revealed that only Nup155 and Nup153 possessed negative missense constraint Z-scores (more variants than expected) with probability of loss of function (LoF) intolerance (pLI) metrics of > 0.9, which infers extreme LoF intolerant genes, while the remaining three NPC proteins (Nup85, Rae1, and Tpr) had a positive Z-score (inferred as increased constraints with fewer variants) with high pLI (Fig. 1b). Furthermore, Nup155 and Nup153 demonstrated consistent significance confirmed by independent volcano plot and quality control thresholding analyses. Of these, Nup155 emerges as the most significantly changed nucleoporin transcript (p = 0.000879), downregulated by more than 3.5-fold in stem cell-derived cardiomyocytes (Fig. 1c).
Dysrhythmia of NUP155 deficient contractile embryoid bodies
Differentiation of ES cells into beating embryoid bodies (EBs) recapitulates cardiac phenotypes of automaticity and electromechanical coupling (Fig. 2). Fluorescent quantitation of Ca2+ transients in wild type control (WT Ctrl) EBs demonstrated constant and regular rhythm (Fig. 2a, b). Treatment of WT Ctrl with the β-adrenergic receptor agonist isoproterenol (Iso, 10 μM) increased the frequency of Ca2+ cycling (Fig. 2c, d) depicted by a significant decrease of time between Ca2+ signal peaks in WT treated EBs compared with WT Ctrl (Fig. 2i). In contrast, unstimulated control NUP155 deficient (NUP155+/− Ctrl) contractile EBs (Fig. 2e) exhibited drastically increased beating frequency, reminiscent of myocardial fibrillation, with variable and diminished amplitude of Ca2+ waves compared to WT EBs (Fig. 2f, j). Isoproterenol stimulation in the NUP155+/− EBs (Fig. 2g) exacerbated the irregularity of the Ca2+ waves, with responses that ranged from a blunted chronotropic effect to loss of agonist response (Fig. 2h), however no difference in interval times was observed compared with NUP155+/− Ctrl (Fig. 2i). Taken together these results show that NUP155-deficient EBs are prone to electrical instability which may serve as a substrate for atrial fibrillation.
Transcriptome remodeling in NUP155-disrupted embryonic stem cells
Dysfunctional contractility in beating EBs is supported by the clinical role of NUP155 in arrhythmogenesis , together with previous reports that have identified gene activation and repression associated with NUP155 in neonatal rat ventricular myocytes . These data suggest a broad capacity for NUP155 to remodel global gene expression profiles in a cardiac setting. To investigate the effects of NUP155 in a cardiogenic context, mouse ES cells that harbor disrupted NUP155 were examined by RNAseq to understand transcriptome changes precipitated by NUP155 in a pluripotent background. Principal component analysis (PCA) plots distinguished WT from NUP155+/− transcriptomes (Fig. 3a). Hierarchical clustering of individual transcriptomes demonstrated clear segregation and reproducibility of gene expression profiles for each biological sample category (Fig. 3b). Replicate analysis was performed to delimit transcripts to those changing by 2.0 fold or greater as well as meeting significance criteria of p < 0.05. A total of 176 and 150 up and downregulated genes were identified that met these criteria (Fig. 3c). Pathway enrichment analysis using DAVID  identified several thematic clusters for up (14 clusters) and downregulated (11 clusters) gene lists (Additional file 1: Tables S1 and S2). The significant functional terms, depicted in Table 1 (p ≤ 0.05), included functions related to integrin alpha for both up and downregulated genes (Upregulated and Downregulated Clusters 1), protein phosphorylation (Upregulated Cluster 2), transmembrane tyrosine protein kinase activity (Up Cluster 3), and cysteine switch/zinc binding (Upregulated Cluster 7, Table 1).
Molecular cartography prioritizes genes within transcriptome subnetworks
Up and downregulated genes were integrated using Ingenuity Pathway Analysis to form a collective de novo gene regulatory network. Gene relationships were extracted and exported for analysis in Cytoscape where they were visualized in a circular layout to emphasize nodes with high edge density (Fig. 4a). Topology analysis confirmed scale-free and hierarchical properties innate to biological networks (Fig. 4b and inset). Neighborhood connectivity (Fig. 4c), betweenness centrality (Fig. 4d) and closeness centrality (Fig. 4e) plots of the integrated NUP155 transcriptome identified preferential attachment nature and bridging nodes key to network connectivity and information flow. The highest betweenness scores in this NUP155-remodeled transcriptome were, in order of priority: APP, HNF4A, TP53, NTRK1, and CTNNB1 (Fig. 4d), whereas the top closeness centrality scores were associated with the same 5 molecules in a different order of priority, i.e. TP53, CTNNB1, NTRK1, APP, and HNF4A (Fig. 4e).
Ingenuity Pathways Analysis reports molecular functional enrichment of each subnetwork within the collective network, and when complemented with DAVID-based analyses, comprehensive functional categories can be identified that one approach alone may not detect, as well as corroborate robust enrichment of consistent gene ontology categories [26,27,28]. This approach revealed the sub-network with the highest significance score (Score = 67) that prioritized Cardiovascular System Development and Function (Fig. 5a). Here, NTRK1/TRKA was integrated as the primary hub with the highest degree, betweenness and closeness centrality coefficients, followed by SRSF2/SC35. (Fig. 5b, c). Specific examination of NTRK1 and SRSF2 expression data in NUP155+/− compared to WT control ES cell lines confirmed significance and magnitude of expression change (Fig. 5d, e). Western blot analysis (Additional file 1: Supplemental Methods) showed that SRSF2 and TRKA protein level changes followed the same trend as gene expression data, however densitometric analysis revealed no significant differences between NUP155+/− and WT (Additional file 1: Figure S1).
A growing body of evidence supports multiple roles for nups in cell fate acquisition, yet the contributions of nups to normal differentiation are incompletely characterized. The present study employs a network strategy to deconvolute multivariate systems biology impacts of NUP155 in a pro-arrhythmogenic embryonic stem cell model of cardiogenesis and captures a capacity for NUP155 to remodel a pluripotent transcriptome. Key molecules associated with cardiac innervation and fibrosis were identified in a module enriched for Cardiovascular Development within a larger NUP155 remodeled network. This work identifies transcriptome recalibration caused by NUP155 deficiency that underlies arrhythmogenic elements, and supports a developmental function for nups beyond canonical roles in NPC architecture and nucleocytoplasmic transport.
To gain insights into allele frequencies of nups that may predispose to cardiac disease, we used the ExAC browser to investigate the anticipated number of variants for the nups we identified in our study, as well as their tolerance (or intolerance) to variation. All nups identified in the present work possess a high pLI score that is expected given the essential role of nucleoporins in eukaryotic cell viability. However, of the 5 identified in this study, Nup85, Rae1, and Tpr demonstrated a positive constraint metric z-score for missense mutations, while Nup155 and Nup153 had negative missense constraint z-scores. This suggests that Nup155 and Nup153 exist within the population with a high tolerance to variation that may present as developmental disease rather than terminal nonviability [30, 38]. Indeed, a landmark clinical study by Zhang et al. identified a mutation in NUP155 that led to atrial fibrillation , while recent work by Nanni et al. identified an altered role for NUP153 in cardiac chromatin regulation in patients with Duchenne muscular dystrophy . In the former study, NUP155 protein levels were normal, with experimental models revealing disrupted nucleocytoplasmic transport that was concluded to be the main cause of arrhythmogenic compromise. The latter study identified a pathological up-regulation of NUP153 combined with increased NUP153 acetylation that led to dysregulated expression of nexilin with calcium channel gain of function . It is of note that NUP155 regulates cardiac hypertrophy through HDAC4 , providing additional evidence for the potential role of nups as epigenomic regulators.
Indeed, the diversity of genes whose expression is dysregulated by NUP155 insufficiency suggests impacts on global mechanisms of gene regulation. In support of this, previous work has reported a capacity for NUP155 to bind, tether and regulate discrete regions of chromatin that control gene expression in yeast and Drosophila models [15, 40]. NUP155 may also act indirectly through interactions with histone modifiers, as described above for studies in rat models of cardiac hypertrophy , or inferred by electronic protein interaction datasets [41, 42]. In the present study, analysis of functional annotation clusters for both up and downregulated revealed consistent enrichment of terms related to membrane interactions and/or transmembrane biology. This was supported by non-clustered significant functional terms (Additional file 1: Tables S3 and S4). Select nucleoporins regulate cell adhesion primarily through altered nucleocytoplasmic trafficking , and NUP155 may influence cell membrane biology via this functional modality since NUP155 is critical for nuclear pore complex assembly, formation, and nuclear transport [13, 44, 45].
Controlled temporospatial execution of molecular programs is required for normal differentiation, driven by the composition and architecture of underlying gene networks. Disruption of these networks recalibrates pluripotency that leads to compromised phenotypes. In the present study, TP53 was prioritized in a molecular framework driven by NUP155 truncation, supported by recent demonstration of TP53 as a master regulator that controls hypertrophic responses of the myocardium . Though investigation of our dataset revealed a non-significant increase in TP53 expression in heterozygous ES cell lines (data not shown), its prioritization in a pluripotent transcriptome network underlying cardiopathological manifestation is reinforced by recent systems biology meta-analyses of disease-causing protein-protein interaction (PPI) networks . Pinero et al. describe in their study a general multiscale mesoscopic molecular signature that underlies disease, where tumor suppressors such as TP53 possess high centrality and are essential hubs within the network structure that are the most sensitive to genomic perturbation. The next prioritized network hubs are dominant disease genes, followed by recessive disease genes in modules with low centrality located at the network periphery . Topology analysis of the present NUP155-recalibrated transcriptome is in line with this biological network property, as homozygous TP53 possesses the highest degree and closeness centrality scores that identify TP53 as a hub that integrates discrete network neighborhoods and determines informational flow among those regions.
NTRK1/TRKA and SRSF2/SC35 were identified here as the most upregulated and downregulated genes with highest degrees, respectively, within the sub-network that prioritizes Cardiovascular System Development, with mRNA and protein expression changes trending in the same direction. Although protein expression changes did not reach significance, such transcript and protein expression discrepancies are expected, given that multiple post-transcriptional and post-translational mechanisms may regulate final expression level . This does not preclude the potential for NUP155 to impact cardiac development through a NUP155-TRKA signaling cascade, however. NTRK1/TRKA is a tyrosine receptor kinase that drives cholinergic differentiation , and has a defined role in promoting cardiac innervation and repair [50, 51]. NTRK1/TRKA directs target cardiac innervation through its effector, CORONIN-1 . This developmental cascade is initiated upon upstream NGF stimulation of NTRK1/TRKA that drives CORONIN-1 mediated calcium release, which negatively regulates axon growth and arborization within the myocardium . Increases in NTRK1/TRKA would facilitate CORONIN-1 suppression of cardiac innervation that would manifest as electrophysiological deficits. This is corroborated by studies that identify increased NTRK1/TRKA levels associated with atrial fibrillation, and is further supported by data that revealed concomitant autocrine and paracrine regulation of NTRK1/TRKA expression by upstream NGF . Further work will clarify this potential NUP155-TRKA axis in the context of cardiac development.
The most downregulated hub identified within this Cardiovascular Development sub-network was SRSF2/SC35, implicated by protein expression data where the trend matched the decrease in SRSF2 mRNA. SRSF2 is a serine/arginine rich splicing factor essential for pluripotent self-renewal, with decreased SRSF2 promoting stem cell differentiation . SRSF2 dynamics are highly regulated in cardiac tissue, as cardiac-specific ablation of SRSF2 results in dilated cardiomyopathy and abnormal Ca2+ handling linked to down-regulation of the cardiac specific ryanodine receptor . Balanced interactions between SRSF2 and TBX5 are necessary for proper pre-mRNA splicing critical for cardiac development . Indeed, disruptions to the TBX5/SRSF2 equilibrium result in Holt-Oram Syndrome, which include cardiac conduction diseases such as AF [57, 58] that can occur alone or in combination with atrial and ventricular septal defects .
Gene networks are highly regulated, stratified structures that can be regulated at multiple levels . Our results identify a mesoscopic cardiac sub-network impacted by NUP155-deficient recalibration of a pluripotent transcriptome. Here, NUP155 insufficiency re-organizes a molecular network that prioritizes TRKA and SRSF2 as potential factors in the development of cardiac AF. The idea that nups may epigenomically remodel the cardiac program is supported by the role of various nups in repressing and/or activating discrete chromatin regions [15, 40, 61,62,63] and previous work that identified regulated nup expression in cardiogenesis . In particular, future work focused on elucidating the role of the splicing factor SRSF2 will provide deeper insights into the epigenomic function and cardiogenic role of NUP155 predicted by the present systems biology study.
- 5’ UTR:
5′ untranslated region
Amyloid beta precursor protein
- Ca2+ :
Database for annotation, visualization and integrated discovery
Fetal bovine serum
Gene expression omnibus
GMEM ES cell media
Hepatocyte nuclear factor 4 alpha
Homeobox A cluster
Leukemia inhibitory factor
Nuclear division cycle homolog 1
Non-essential amino acids
Nerve growth factor
Sodium/hydrogen exchanger 1
Nuclear pore complex
Tropomyosin related kinase A
- Nup155+/− :
NUP155 exon trapped cell line
Phosphate buffered saline
Ribonucleic acid export 1
Region of interest
Serine/arginine rich splicing factor 2
T-box protein 5
Tumor protein 53
Translocated promoter region
January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the Heart Rhythm Society. Circulation. 2014;130(23):2071–104. https://doi.org/10.1161/CIR.0000000000000040.
Reinier K, Marijon E, Uy-Evanado A, Teodorescu C, Narayanan K, Chugh H, et al. The association between atrial fibrillation and sudden cardiac death. JACC Heart Fail. 2014;2(3):221–7. https://doi.org/10.1016/j.jchf.2013.12.006.
Mirza M, Strunets A, Shen WK, Jahangir A. Mechanisms of arrhythmias and conduction disorders in older adults. Clin Geriatr Med. 2012;28(4):555–73. https://doi.org/10.1016/j.cger.2012.08.005.
Fye WB. Tracing atrial fibrillation--100 years. N Engl J Med. 2006;355(14):1412–4. https://doi.org/10.1056/NEJMp068059.
Blagova OV, Nedostup AV, Kogan EA, Sulimov VA, Abugov SA, Kupriyanova AG, et al. Myocardial Biopsy In “Idiopathic” Atrial Fibrillation And Other Arrhythmias: Nosological Diagnosis, Clinical And Morphological Parallels, And Treatment. J Atr Fibrillation. 2016;9(1):1414. https://doi.org/10.4022/jafib.1414.
Perez-Serra A, Campuzano O, Brugada R. Update about atrial fibrillation genetics. Curr Opin Cardiol. 2017;32(3):246–52. https://doi.org/10.1097/HCO.0000000000000387.
Tucker NR, Ellinor PT. Emerging directions in the genetics of atrial fibrillation. Circ Res. 2014;114(9):1469–82. https://doi.org/10.1161/CIRCRESAHA.114.302225.
Olesen MS, Nielsen MW, Haunso S, Svendsen JH. Atrial fibrillation: the role of common and rare genetic variants. Eur J Hum Genet. 2014;22(3):297–306. https://doi.org/10.1038/ejhg.2013.139.
Callan HG, Tomlin SG. Experimental studies on amphibian oocyte nuclei. I. Investigation of the structure of the nuclear membrane by means of the electron microscope. Proc R Soc Lond B Biol Sci. 1950;137(888):367–78.
von Appen A, Beck M. Structure determination of the nuclear pore complex with three-dimensional Cryo electron microscopy. J Mol Biol. 2016;428(10 Pt A):2001–10. https://doi.org/10.1016/j.jmb.2016.01.004.
Alber F, Dokudovskaya S, Veenhoff LM, Zhang W, Kipper J, Devos D, et al. The molecular architecture of the nuclear pore complex. Nature. 2007;450(7170):695–701. https://doi.org/10.1038/nature06405.
Vollmer B, Lorenz M, Moreno-Andres D, Bodenhofer M, De Magistris P, Astrinidis SA, et al. Nup153 recruits the Nup107-160 complex to the inner nuclear membrane for Interphasic nuclear pore complex assembly. Dev Cell. 2015;33(6):717–28. https://doi.org/10.1016/j.devcel.2015.04.027.
Schwartz M, Travesa A, Martell SW, Forbes DJ. Analysis of the initiation of nuclear pore assembly by ectopically targeting nucleoporins to chromatin. Nucleus. 2015;6(1):40–54. https://doi.org/10.1080/19491034.2015.1004260.
Gomez-Cavazos JS, Hetzer MW. The nucleoporin gp210/Nup210 controls muscle differentiation by regulating nuclear envelope/ER homeostasis. J Cell Biol. 2015;208(6):671–81. https://doi.org/10.1083/jcb.201410047.
Breuer M, Ohkura H. A negative loop within the nuclear pore complex controls global chromatin organization. Genes Dev. 2015;29(17):1789–94. https://doi.org/10.1101/gad.264341.115.
Capelson M, Hetzer MW. The role of nuclear pores in gene regulation, development and disease. EMBO Rep. 2009;10(7):697–705. https://doi.org/10.1038/embor.2009.147.
Dickmanns A, Kehlenbach RH, Fahrenkrog B. Nuclear pore complexes and nucleocytoplasmic transport: From Structure to Function to Disease. Int Rev Cell Mol Biol. 2015;320:171–233. https://doi.org/10.1016/bs.ircmb.2015.07.010.
Beck M, Hurt E. The nuclear pore complex: understanding its function through structural insight. Nat Rev Mol Cell Biol. 2017;18:73-89. https://doi.org/10.1038/nrm.2016.147.
Zhang X, Chen S, Yoo S, Chakrabarti S, Zhang T, Ke T, et al. Mutation in nuclear pore component NUP155 leads to atrial fibrillation and early sudden cardiac death. Cell. 2008;135(6):1017–27. https://doi.org/10.1016/j.cell.2008.10.022.
Tarazon E, Rivera M, Rosello-Lleti E, Molina-Navarro MM, Sanchez-Lazaro IJ, Espana F, et al. Heart failure induces significant changes in nuclear pore complex of human cardiomyocytes. PLoS One. 2012;7(11):e48957. https://doi.org/10.1371/journal.pone.0048957.
Labade AS, Karmodiya K, Sengupta K. HOXA repression is mediated by nucleoporin Nup93 assisted by its interactors Nup188 and Nup205. Epigenetics Chromatin. 2016;9:e54. https://doi.org/10.1186/s13072-016-0106-0.
Di-Poi N, Koch U, Radtke F, Duboule D. Additive and global functions of HoxA cluster genes in mesoderm derivatives. Dev Biol. 2010;341(2):488–98. https://doi.org/10.1016/j.ydbio.2010.03.006.
Del Viso F, Huang F, Myers J, Chalfant M, Zhang Y, Reza N, et al. Congenital heart disease genetics uncovers context-dependent organization and function of nucleoporins at cilia. Dev Cell. 2016;38(5):478–92. https://doi.org/10.1016/j.devcel.2016.08.002.
Cortes R, Rosello-Lleti E, Rivera M, Martinez-Dolz L, Salvador A, Azorin I, et al. Influence of heart failure on nucleocytoplasmic transport in human cardiomyocytes. Cardiovasc Res. 2010;85(3):464–72. https://doi.org/10.1093/cvr/cvp336.
Xu L, Pan L, Li J, Huang B, Feng J, Li C, et al. Nucleoporin 35 regulates cardiomyocyte pH homeostasis by controlling Na+-H+ exchanger-1 expression. J Mol Cell Biol. 2015;7(5):476–85. https://doi.org/10.1093/jmcb/mjv054.
Faustino RS, Behfar A, Perez-Terzic C, Terzic A. Genomic chart guiding embryonic stem cell cardiopoiesis. Genome Biol. 2008;9(1):R6. https://doi.org/10.1186/gb-2008-9-1-r6.
Faustino RS, Wyles SP, Groenendyk J, Michalak M, Terzic A, Perez-Terzic C. Systems biology surveillance decrypts pathological transcriptome remodeling. BMC Syst Biol. 2015;9:36. https://doi.org/10.1186/s12918-015-0177-8.
Faustino RS, Chiriac A, Niederlander NJ, Nelson TJ, Behfar A, Mishra PK, et al. Decoded calreticulin-deficient embryonic stem cell transcriptome resolves latent cardiophenotype. Stem Cells. 2010;28(7):1281–91. https://doi.org/10.1002/stem.447.
The Exome Aggregation Consortium (ExAC) browser. http://exac.broadinstitute.org/. Accessed 10 Nov 2017.
Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536(7616):285–91. https://doi.org/10.1038/nature19057.
The Database for Annotation, Visualization and Integrated Discovery (DAVID) v6.8. https://david.ncifcrf.gov/. Accessed 5 May 2017.
Huang DW, Sherman BT, Tan Q, Collins JR, Alvord WG, Roayaei J, et al. The DAVID gene functional classification tool: a novel biological module-centric algorithm to functionally analyze large gene lists. Genome Biol. 2007;8(9):R183. https://doi.org/10.1186/gb-2007-8-9-r183.
Huang DW, Sherman BT, Tan Q, Kir J, Liu D, Bryant D, et al. DAVID bioinformatics resources: expanded annotation database and novel algorithms to better extract biology from large gene lists. Nucleic Acids Res. 2007;35(Web Server issue):W169–75. https://doi.org/10.1093/nar/gkm415.
Huang d W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44–57. https://doi.org/10.1038/nprot.2008.211.
Cytoscape software platform. http://www.cytoscape.org/. Accessed 5 May 2017.
Perez-Terzic C, Faustino RS, Boorsma BJ, Arrell DK, Niederlander NJ, Behfar A, et al. Stem cells transform into a cardiac phenotype with remodeling of the nuclear transport machinery. Nat Clin Pract Cardiovasc Med. 2007;4(Suppl 1):S68–76. https://doi.org/10.1038/ncpcardio0763.
Kehat I, Accornero F, Aronow BJ, Molkentin JD. Modulation of chromatin position and gene expression by HDAC4 interaction with nucleoporins. J Cell Biol. 2011;193(1):21–9.
Petrovski S, Wang Q, Heinzen EL, Allen AS, Goldstein DB. Genic intolerance to functional variation and the interpretation of personal genomes. PLoS Genet. 2013;9(8):e1003709. https://doi.org/10.1371/journal.pgen.1003709.
Nanni S, Re A, Ripoli C, Gowran A, Nigro P, D'Amario D, et al. The nuclear pore protein Nup153 associates with chromatin and regulates cardiac gene expression in dystrophic mdx hearts. Cardiovasc Res. 2016;112(2):555–67. https://doi.org/10.1093/cvr/cvw204.
Van de Vosse DW, Wan Y, Lapetina DL, Chen WM, Chiang JH, Aitchison JD, et al. A role for the nucleoporin Nup170p in chromatin structure and gene silencing. Cell. 2013;152(5):969–83. https://doi.org/10.1016/j.cell.2013.01.049.
STRING v10.5. https://string-db.org/. Accessed 6 Apr 2018.
GeneCards: Human Gene Database http://www.genecards.org/. Accessed 6 Apr 2018.
Funasaka T, Balan V, Raz A, Wong RW. Nucleoporin Nup98 mediates galectin-3 nuclear-cytoplasmic trafficking. Biochem Biophys Res Commun. 2013;434(1):155–61. https://doi.org/10.1016/j.bbrc.2013.03.052.
De Magistris P, Tatarek-Nossol M, Dewor M, Antonin W. A self-inhibitory interaction within Nup155 and membrane binding are required for nuclear pore complex formation. J Cell Sci. 2018;131:1-9. jcs208538. https://doi.org/10.1242/jcs.208538.
Eisenhardt N, Redolfi J, Antonin W. Interaction of Nup53 with Ndc1 and Nup155 is required for nuclear pore complex assembly. J Cell Sci. 2014;127(Pt 4):908–21. https://doi.org/10.1242/jcs.141739.
Mak TW, Hauck L, Grothe D, Billia F. p53 regulates the cardiac transcriptome. Proc Natl Acad Sci U S A. 2017;114(9):2331–6. https://doi.org/10.1073/pnas.1621436114.
Pinero J, Berenstein A, Gonzalez-Perez A, Chernomoretz A, Furlong LI. Uncovering disease mechanisms through network biology in the era of next generation sequencing. Sci Rep. 2016;6:24570. https://doi.org/10.1038/srep24570.
Gan H, Cai T, Lin X, Wu Y, Wang X, Yang F, et al. Integrative proteomic and transcriptomic analyses reveal multiple post-transcriptional regulatory mechanisms of mouse spermatogenesis. Mol Cell Proteomics. 2013;12(5):1144–57. https://doi.org/10.1074/mcp.M112.020123.
Wang L, He F, Zhong Z, Lv R, Xiao S, Liu Z. Overexpression of NTRK1 promotes differentiation of neural stem cells into cholinergic neurons. Biomed Res Int. 2015;2015:857202. https://doi.org/10.1155/2015/857202.
Meloni M, Caporali A, Graiani G, Lagrasta C, Katare R, Van Linthout S, et al. Nerve growth factor promotes cardiac repair following myocardial infarction. Circ Res. 2010;106(7):1275–84. https://doi.org/10.1161/CIRCRESAHA.109.210088.
Lorentz CU, Alston EN, Belcik T, Lindner JR, Giraud GD, Habecker BA. Heterogeneous ventricular sympathetic innervation, altered beta-adrenergic receptor expression, and rhythm instability in mice lacking the p75 neurotrophin receptor. Am J Physiol Heart Circ Physiol. 2010;298(6):H1652–60. https://doi.org/10.1152/ajpheart.01128.2009.
Suo D, Park J, Young S, Makita T, Deppmann CD. Coronin-1 and calcium signaling governs sympathetic final target innervation. J Neurosci. 2015;35(9):3893–902. https://doi.org/10.1523/JNEUROSCI.4402-14.2015.
Saygili E, Schauerte P, Kuppers F, Heck L, Weis J, Weber C, et al. Electrical stimulation of sympathetic neurons induces autocrine/paracrine effects of NGF mediated by TrkA. J Mol Cell Cardiol. 2010;49(1):79–87. https://doi.org/10.1016/j.yjmcc.2010.01.019.
Lu Y, Loh YH, Li H, Cesana M, Ficarro SB, Parikh JR, et al. Alternative splicing of MBD2 supports self-renewal in human pluripotent stem cells. Cell Stem Cell. 2014;15(1):92–101. https://doi.org/10.1016/j.stem.2014.04.002.
Ding JH, Xu X, Yang D, Chu PH, Dalton ND, Ye Z, et al. Dilated cardiomyopathy caused by tissue-specific ablation of SC35 in the heart. EMBO J. 2004;23(4):885–96. https://doi.org/10.1038/sj.emboj.7600054.
Fan C, Chen Q, Wang QK. Functional role of transcriptional factor TBX5 in pre-mRNA splicing and Holt-Oram syndrome via association with SC35. J Biol Chem. 2009;284(38):25653–63. https://doi.org/10.1074/jbc.M109.041368.
Cerbai E, Sartiani L. Holt-oram syndrome and atrial fibrillation: opening the (T)-box. Circ Res. 2008;102(11):1304–6. https://doi.org/10.1161/CIRCRESAHA.108.178079.
Baruteau AE, Probst V, Abriel H. Inherited progressive cardiac conduction disorders. Curr Opin Cardiol. 2015;30(1):33–9. https://doi.org/10.1097/HCO.0000000000000134.
Jhang WK, Lee BH, Kim GH, Lee JO, Yoo HW. Clinical and molecular characterisation of Holt-Oram syndrome focusing on cardiac manifestations. Cardiol Young. 2015;25(6):1093–8. https://doi.org/10.1017/S1047951114001656.
Kobayashi T, Masuda N. Fragmenting networks by targeting collective influencers at a mesoscopic level. Sci Rep. 2016;6:37778. https://doi.org/10.1038/srep37778.
Seo HS, Blus BJ, Jankovic NZ, Blobel G. Structure and nucleic acid binding activity of the nucleoporin Nup157. Proc Natl Acad Sci U S A. 2013;110(41):16450–5. https://doi.org/10.1073/pnas.1316607110.
Lapetina DL, Ptak C, Roesner UK, Wozniak RW. Yeast silencing factor Sir4 and a subset of nucleoporins form a complex distinct from nuclear pore complexes. J Cell Biol. 2017;216(10):3145–59. https://doi.org/10.1083/jcb.201609049.
Toda T, Hsu JY, Linker SB, Hu L, Schafer ST, Mertens J, et al. Nup153 interacts with Sox2 to enable bimodal gene regulation and maintenance of neural progenitor cells. Cell Stem Cell. 2017;21(5):618–34 e7. https://doi.org/10.1016/j.stem.2017.08.012.
We are grateful for the help provided by Dr. Jin Jen and the Genome Analysis Core within the Medical Genome Facility at the Mayo Clinic, Rochester MN; and discussions with Dr. Johan Martijn Bos on the genetics of arrhythmias and the ExAC browser.
All aspects of this work, including study design, data collection, analysis, interpretation, and writing of the manuscript was supported by Sanford Research and by the American Heart Association (Grant # 14SDG20380322).
Availability of data and materials
All data generated or analyzed during this study are included in this published article (and its Additional file).
Ethics approval and consent to participate
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Table S1. Pathway Enrichment Analysis of Upregulated Genes. Table S2. Pathway Enrichment Analysis of Downregulated Genes. Table S3. Functional terms not clustered during pathway enrichment analysis of Upregulated genes. Table S4. Functional terms not clustered during pathway enrichment analysis of Downregulated genes. Supplemental Methods: Western Blot Analysis. Figure S1. Protein Expression data for SRSF2/SC35 and NTRK1/TRKA. Western blots of a SRSF2/SC35 and b NTRK1/TRKA from Wild Type (WT, n = 4) and Nup155+/− (n = 4) ES cell lines. β tubulin was used as loading control for both proteins. Comparison of normalized ratios from densitometry analyses of c SRSF2/SC35 and (D) NTRK1/TRKA protein levels in WT and Nup155+/− cell lines (p > 0.05). (PDF 416 kb)